Quantitative COVID-19 SARS-CoV-2 Antibody Pre and Post Cardiopulmonary Bypass
NCT05357885 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2022-05-03
Summary
This study is designed to compare the levels of SARS-CoV-2 antibody prior to cardiopulmonary bypass and after cardiopulmonary bypass (CPB).
Conditions
- Laboratory Assessment SARS-CoV-2 Antibody Levels Before and After Surgery for Patients Requiring Cardiopulmonary Bypass
Interventions
- DIAGNOSTIC_TEST
-
SARS-CoV-2 Antibody test
SARS-CoV-2 antibody test at Jefferson is Roche Elecsys Anti-SARS-CoV-2 immunoassays performed under FDA's Emergency Use Authorization.
Sponsors & Collaborators
-
Thomas Jefferson University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-17
- Primary Completion
- 2022-03-17
- Completion
- 2022-03-17
Countries
- United States
Study Locations
More Related Trials
-
Cardiopulmonary Exercise Testing as an Outcome Predictor in Coronary Artery Bypass Surgery
NCT03376542 ·Status: COMPLETED ·Phase: NA
-
Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT
NCT00259493 ·Status: UNKNOWN ·Phase: NA
-
Optimizing Pulsatility During Cardiopulmonary Bypass
NCT05344573 ·Status: RECRUITING
-
Exploration of Cerebral Pathophysiology During and After CABG Using CPB
NCT02941380 ·Status: COMPLETED
-
Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study
NCT00463294 ·Status: COMPLETED ·Phase: PHASE3
-
Best Bypass Surgery (BBS) Trial
NCT00120991 ·Status: UNKNOWN ·Phase: PHASE3
-
Predictors of Postoperative Atrial Fibrillation After CABG
NCT05888168 ·Status: UNKNOWN
-
Cardiopulmonary Bypass and Ventricular Remodeling
NCT06256965 ·Status: COMPLETED
-
Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass
NCT06839027 ·Status: NOT_YET_RECRUITING
-
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
NCT04296071 ·Status: RECRUITING
-
Aortic-Radial Pressure Gradients Post CPB
NCT03142815 ·Status: COMPLETED
-
Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function
NCT01469676 ·Status: COMPLETED ·Phase: NA
-
Randomized Clinical Trial Comparing Coronary Bypass Grafting With or Without Cardiopulmonary Bypass
NCT00216957 ·Status: COMPLETED ·Phase: PHASE3
-
Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
NCT00812656 ·Status: COMPLETED
-
Study Of Factors Favoring The Onset Of Novo Atrial Fibrillation In The Immediate Aftermath Of Coronary Artery Bypass Surgery
NCT02042547 ·Status: COMPLETED
-
Prolonged Cardiopulmonary Bypass Time as a Predictive Factor for AGI After Heart Valve Replacement
NCT05498935 ·Status: COMPLETED
-
Changes in Gene Expression and Prognosis of Blood Immune Cells After Cardiopulmonary Bypass Surgery
NCT05871203 ·Status: UNKNOWN
-
Postoperative Use Of Pump Blood İn Cardiopulmonary Bypass Surgery
NCT06824753 ·Status: COMPLETED ·Phase: NA
-
CABG Without the Use of CPB
NCT00202332 ·Status: COMPLETED ·Phase: PHASE2
-
Prolonged Cardiopulmonary Bypass Time as Predictive Factor for in Hospital Infection
NCT04548167 ·Status: COMPLETED
-
Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution
NCT03326323 ·Status: COMPLETED
-
Evaluation of TEG 6S PM® During Cardiopulmonary Bypass to Detect Postoperative Biological Coagulopathy
NCT06230640 ·Status: COMPLETED
-
Haemostatic Markers in Cardiopulmonary Bypass
NCT03861286 ·Status: COMPLETED
-
Cardiopulmonary Bypass (CPB) Pumps and Blood Activation
NCT00187967 ·Status: UNKNOWN ·Phase: NA
-
Feasibility of Perioperative Stellate Ganglion Blocks in Cardiac Surgery
NCT02784587 ·Status: COMPLETED ·Phase: NA